knowledge -WSS

knowledge

author：Wikipedia 2025-09-30 18:20:25 - browse：645

Light hits on the portrait of George Washington on a one dollar bill. The portrait is surrounded by white and red tablets coming out of a pill bottle, as well as some coins — coverage from STAT — Adobe

WASHINGTON — Pharmaceutical companies are doing anything they can to stop President Biden’s Medicare program from being able to negotiate prices for their products, including suing the government. Experts say their efforts might actually benefit Biden by reminding voters that he’s taking on big drug companies.

When Democrats passed a law directing Medicare to negotiate drug prices, it was considered a major achievement. The new law, two decades in the making, gives Biden an accomplishment to both tout for himself and criticize Republicans for opposing — no Republicans voted to let Medicare negotiate drug prices.

Medicare price negotiation is popular with voters, as are the law’s price-inflation limits, and it includes additional, direct benefits for older adults that are easy to understand. It caps annual out-of-pocket retail-drug spending for seniors and people with disabilities, and it caps their monthly spending on insulin at $35.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Trump’s hydroxychloroquine hype: a risk to my treatment and to him

WSS

Hubble vs. James Webb telescope images: See the difference

Custom gene therapy hints at new path for rare disease treatments

How dance can help nurses traumatized by Covid

Group opposing PBM reform sets lobbying record

What affirmative action's end means to a medical student

A letter from the executive editor: The 2023 STATUS List

entertainment

knowledge

focus

Supreme Court strikes down use of affirmative action

Canadians with cystic fibrosis outlive Americans by a decade

What does generative AI mean for health care? We asked experts

Biden tests positive for Covid

Hepatitis C has a cure — but many Americans still lack access to it

Why hospitals are withdrawing from US News rankings

Trump demands the U.S. pay no more for drugs than other countries … again

A public scorecard can help hold safety

Trump demands the U.S. pay no more for drugs than other countries … again

Startup Neumora takes a novel depression drug to Phase 3

focus

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

Security flaws in third

Being 'nonadherent' patient made me a more empathetic doctor

A letter from the executive editor: The 2023 STATUS List

Sanofi seeks simpler, safer CRISPR sickle cell cure

hotspot

Wikipedia

hotspot

focus